6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement

Posted Date: Dec 10, 2025
Dec 29, 2025
Awarded Date: No Awarded Date
SetAside Type
Service-Disabled Veteran-Owned Small Business Set Aside
Solicitation ID Solicitation Title Solicitation Office
36C24826Q0145 6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement
Synopsis
The Orlando VA Healthcare System and Caribbean VA Healthcare System intends to solicit and award an acquisition for Thyroid Cancer Molecular Test. The performance period for this contract will be date of award to date of completion. The Primary North American Industry Classification System (NAICS) for this acquisition is 621511, with a related small business size standard of $41.5 Million. The proposed action is for Firm-Fixed Price (FFP) requirement contract, which will be advertised as a set aside to service-disabled veteran owned small business on or about 15 December 2025, via sam.gov website. The solicitation and incorporated provisions and clauses .... Read More
Office Location Agency Name Solicitation Base Posting Type
VETERANS AFFAIRS, DEPARTMENT OF Presolicitation
An error has occurred. This application may no longer respond until reloaded. Reload 🗙